Scientists at Fujita Health University in Japan found that an isolated soy-derived lysophospholipid called LPC70 can mitigate the detrimental cardiovascular and cognitive effects of a high-sodium diet, Newsmonkey reported.
Excessive salt consumption typically drives up blood pressure while impairing cognitive functions such as social interaction and object recognition. The experimental study demonstrated that administering LPC70 limited these blood pressure spikes and improved behavioral outcomes in animal subjects.
The compound operates across multiple biological pathways to protect different organ systems simultaneously. In the kidneys, LPC70 helps stabilize specific proteins required for blood pressure regulation, according to the research published in Neurochemistry International.
Researchers observed that the substance restored receptor activity within the prefrontale cortex, which is the brain region responsible for decision-making and behavior that high salt intake otherwise damages. Prostaglandins, which are signaling molecules managing vascular regulation, inflammation, and nervous system functions, served as the primary focus of the investigation.
Investigators emphasize that the current findings remain limited to animal models tested with a concentrated substance rather than whole soy products. Because biological responses vary significantly between tissues, further clinical trials involving human subjects are necessary to determine if LPC70 supplements are safe and effective.
Dietary Guidelines Remain Unchanged
Medical experts stress that these experimental results do not justify increasing daily salt consumption or replacing established medical treatments. Active reduction of sodium intake remains the most effective strategy for lowering health risks, as current dietary guidelines stay firmly in place.
Frequently Asked Questions
What specific food source provides LPC70?
LPC70 is a concentrated lysofosfolipide derived from soybeans, though researchers used a purified, concentrated substance rather than whole soy products in their experiments.
Which academic institution conducted the study?
Scientists at Fujita Health University in Japan carried out the experimental research, which was subsequently published in the journal Neurochemistry International.
Can humans start taking LPC70 supplements immediately for high blood pressure?
No, human trials have not yet taken place, and researchers warn that further clinical testing is required before any medical application or supplement use can be considered.
Worth a look